pillbase.ru

Beyfortus

Active substance: nirsevimab

nirsevimab

Centralised EU authorisationActive

Marketing holder: Sanofi Winthrop Industrie

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 2
  • BEYFORTUS
    INJECTION · NIRSEVIMAB 100 mg/mL
    49281-574
    Sanofi Vaccines US Inc.
  • BEYFORTUS
    INJECTION · NIRSEVIMAB 100 mg/mL
    49281-575
    Sanofi Vaccines US Inc.
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208f-be00-7957-b4ac-b45ab5c158c4,01a1209d-61e3-7ea0-965d-bd6a77126dcc;count=2 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/005304
Registration status
Active
ATC code
J06BD08
Sources
  • product · EMA · EMEA/H/C/005304 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/005304 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/005304 · Verified 2026-10-09